| 31. |
|
|
| 32. |
- Janjic, J., et al.
(författare)
-
In-vitro sonothrombolysis using thick-shelled polymer microbubbles-a comparison with thin-shelled microbubbles
- 2020
-
Ingår i: Cardiovascular Ultrasound. - : BioMed Central. - 1476-7120. ; 18:1
-
Tidskriftsartikel (refereegranskat)abstract
- Background: Vascular thrombosis can be treated pharmacologically, however, serious shortcomings such as bleeding may occur. Several studies suggest that sonothrombolysis can induce lysis of the clots using ultrasound. Moreover, intravenously injected thin-shelled microbubbles (MBs) combined with ultrasound can further improve clot lysis. Thick-shelled MBs have been used for drug delivery, targeting and multimodal imaging. However, their capability to enhance sonothrombolysis is unknown. In this study, using an in-vitro set-up, the enhancement of clot lysis using ultrasound and thick-shelled MBs was investigated. Thin-shelled MBs was used for comparison. Method: The main components in the in-vitro set-up was a vessel mimicking phantom, a pressure mearing system and programmable ultrasound machine. Blood clots were injected and entrapped on a pore mesh in the vessel phantom. Four different protocols for ultrasound transmission and MB exposure (7 blood clots/protocol) were considered together with a control test were no MBs and ultrasound were used. For each protocol, ultrasound exposure of 20 min was used. The upstream pressure of the partially occluded mesh was continuously measured to assess clot burden. At the end of each protocol blood clots were removed from the phantom and the clot mass loss was computed. Results: For the thick-shelled MBs no difference in clot mass loss compared with the control tests was found. A 10% increase in the clot mass loss compared with the control tests was found when using thin-shelled MBs and low pressure/long pulses ultrasound exposure. Similarly, in terms of upstream pressure over exposure time, no differences were found when using the thick-shelled MBs, whereas thin-shelled MBs showed a 15% decrease achieved within the first 4 min of ultrasound exposure. Conclusion: No increase in clot lysis was achieved using thick-shelled MBs as demonstrated by no significant change in clot mass or upstream pressure. Although thick-shelled MBs are promising for targeting and drug delivery, they do not enhance clot lysis when considering the ultrasound sequences used in this study. On the other hand, ultrasound in combination with thin-shelled MBs can facilitate thrombolysis when applying long ultrasound pulses with low pressure.
|
|
| 33. |
- Josefsson, Leila, et al.
(författare)
-
Analysis of polyvinyl alcohol microbubbles in human blood plasma using capillary electrophoresis
- 2016
-
Ingår i: Journal of Separation Science. - : Wiley-VCH Verlagsgesellschaft. - 1615-9306 .- 1615-9314. ; 39:8, s. 1551-1558
-
Tidskriftsartikel (refereegranskat)abstract
- Recently, a new type of ultrasound contrast agent that consists of air-filled microbubbles stabilized with a shell of polyvinyl alcohol was developed. When superparamagnetic nanoparticles of iron oxide are incorporated in the polymer shell, a multimodal contrast agent can be obtained. The biodistribution and elimination pathways of the polyvinyl alcohol microbubbles are essential to investigate, which is limited with today's techniques. The aim of the present study was, therefore, to develop a method for qualitative and quantitative analysis of microbubbles in biological samples using capillary electrophoresis with ultraviolet detection. The analysis parameters were optimized to a wavelength at 260 nm and pH of the background electrolyte ranging between 11.9 and 12. Studies with high-intensity ultrasonication degraded microbubbles in water showed that degraded products and intact microbubbles could be distinguished, thus it was possible to quantify the intact microbubbles solely. Analysis of human blood plasma spiked with either plain microbubbles or microbubbles with nanoparticles demonstrated that it is possible to separate them from biological components like proteins in these kinds of samples.
|
|
| 34. |
|
|
| 35. |
- Larsson, Malin, 1983-, et al.
(författare)
-
A new ultrasound-based approach to visualize target specific polymeric contrast agent
- 2011
-
Ingår i: 2011 IEEE International Ultrasonics Symposium (IUS). - : IEEE. - 9781457712524 ; , s. 1626-1629
-
Konferensbidrag (refereegranskat)abstract
- There are advantages of using a polymeric shelled contrast agent (CA) during ultrasound imaging instead of lipid shelled CA, e.g. particles can be attached to the surface, which enables an introduction of antibodies to the surface making the CA target specific. For this application it is essential to have a sensitive imaging technique suitable for polymeric CA. However, previously presented results have indicated difficulties in visualizing polymeric CA with commercially available contrast algorithms. Therefore a new subtraction algorithm (SA), was developed that define the difference between contrast and reference images. The aim of this study was to evaluate the response from a polymeric CA, when using the SA and compare it with existing contrast algorithms. Moreover, the possibility to detect a thin layer of CA was tested using the SA.Ultrasound short-axis images of a tissue-mimicking vessel phantom with a pulsating flow were obtained using a GE Vivid7 system (M12L) and a Philips iE33 system (S5-1). Repeated (n=91) contrast to tissue ratios (CTR) calculated at various mechanical index (MI) using the contrast algorithms pulse inversion (PI), power modulation (PM) and SA at a concentration of 105microbubbles/ml.The developed SA showed improvements in CTR compared to existing contrast algorithms. The CTRs were -0.99 dB ± 0.67 (MI 0.2), 9.46 dB ± 0.77 (MI 0.4) and 2.98 dB ± 0.60 (MI 0.8) with PI, 8.17 dB ± 1.15 (MI 0.2), 15.60 dB ± 1.29 (MI0.4) and 11.60 dB ± 0.73 (MI 0.8) with PM and 14.97 dB ± 3.97 (MI 0.2), 20.89 dB ± 3.54 (MI 0.4) and 21.93 dB ± 4.37 (MI 0.8) with the SA. In addition to this, the layer detection, when using the SA was successful.
|
|
| 36. |
|
|
| 37. |
|
|
| 38. |
- Larsson, Matilda, et al.
(författare)
-
In-vivo assessment of radial and longitudinal strain in the carotid artery using speckle tracking
- 2010
-
Ingår i: 2010 IEEE International Ultrasonics Symposium Proceedings. - : IEEE. - 9781457703829 ; , s. 1328-1331
-
Konferensbidrag (refereegranskat)abstract
- Ultrasound-based algorithms are commonly used to assess mechanical properties of arterial walls in studies of arterial stiffness and atherosclerosis. Speckle tracking based techniques used for estimation of myocardial strain can be applied on vessels to estimate strain of the arterial wall. Previous elastography studies in vessels have mainly focused on radial strain measurements, whereas the longitudinal strain has been more or less ignored. However, recently we showed the feasibility of speckle tracking to assess longitudinal strain of the carotid artery in-silico. The aim of this study was to test this methodology in-vivo. Ultrasound images were obtained in seven healthy subjects with no known cardiovascular disease (39 ± 14 years old) and in seven patients with coronary artery disease (CAD), (69 ± 4 years old). Speckle tracking was performed on the envelope detected data using our previous developed algorithm. Radial and longitudinal strains were estimated throughout two cardiac cycles in a region of interest (ROI) positioned in the posterior vessel wall. The mean peak systolic radial and longitudinal strain values from the two heart cycles were compared between the groups using a student's t-test. The mean peak radial strain was -39.1 ± 15.1% for the healthy group and -20.4 ± 7.5% for the diseased group (p = 0.01), whereas the mean peak longitudinal strain was 4.8 ± 1.1% and 3.2 ± 1.6% (p = 0.05) for the healthy and diseased group, respectively. Both peak radial and longitudinal strain values were thus significantly reduced in the CAD patient group. This study shows the feasibility to estimate radial and longitudinal strain in-vivo using speckle tracking and indicates that the method can detect differences between groups of healthy and diseased (CAD) subjects.
|
|
| 39. |
- Larsson, Malin K., et al.
(författare)
-
Endocardial border delineation capability of a multimodal polymer-shelled contrast agent
- 2014
-
Konferensbidrag (övrigt vetenskapligt/konstnärligt)abstract
- BackgroundA novel polymer-shelled contrast agent (CA) with high mechanical and chemical stability was recently developed [1]. In excess to its ultrasound properties, it also supports targeted and multimodal imaging [2-4]. Even though these new possibilities have the potential to lead to new methodologies and approaches for non-invasive diagnosis, it is important that the fundamental diagnostic features in contrast-enhanced ultrasound are preserved. The aim of this study was therefore to examine the clinical use of the polymer-shelled CA by analyzing the left ventricular endocardial border delineation capability in a porcine model. In addition, physiological effects due to CA injections were studied.MethodsThe endocardial border delineation capability was assessed in a comparative study, which included three doses (1.5 ml, 3 ml and 5 ml, [5x108 MBs/ml]) of the polymer-shelled CA and the commercially available CA SonoVue® (1.5 ml, [2-5x108 MBs/ml]). Ultrasound images of the left ventricle were evaluated manually by blinded observers (n=3) according to a 6-segment model, in which each segment was graded as 0=not visible, 1=barely visible or 2=well visible, as well as semi-automatically by a segmentation software. Furthermore, duration of clinically useful contrast enhancement and changes in physiological parameters were evaluated.ResultsFor the highest dose of the polymer-shelled CA, the obtained segment scores, time for clinically sufficient contrast enhancement and semi-automatic delineation capability were comparable to SonoVue®. Moreover, neither dose of the polymer-shelled CA did affect the physiological parameters.ConclusionThis study demonstrated that the polymer-shelled CA can be used in contrast-enhanced diagnostic imaging without influence on major physiological parameters.
|
|
| 40. |
- Larsson, Malin K., et al.
(författare)
-
Endocardial border delineation capability of a novel multimodal polymer-shelled contrast agent
- 2014
-
Ingår i: Cardiovascular Ultrasound. - : Springer Science and Business Media LLC. - 1476-7120. ; 12, s. 24-
-
Tidskriftsartikel (refereegranskat)abstract
- Background: A novel polymer-shelled contrast agent (CA) with multimodal and target-specific potential was developed recently. To determine its ultrasonic diagnostic features, we evaluated the endocardial border delineation as visualized in a porcine model and the concomitant effect on physiological variables. Methods: Three doses of the novel polymer-shelled CA (1.5 ml, 3 ml, and 5 ml [5 x 10(8) microbubbles (MBs)/ml]) and the commercially available CA SonoVue (1.5 ml [2-5 x 10(8) MBs/ml]) were used. Visual evaluations of ultrasound images of the left ventricle were independently performed by three observers who graded each segment in a 6-segment model as either 0 = not visible, 1 = weakly visible, or 2 = visible. Moreover, the duration of clinically useful contrast enhancement and the left ventricular opacification were determined. During anesthesia, oxygen saturation, heart rate, and arterial pressure were sampled every minute and the effect of injection of CA on these physiological variables was evaluated. Results: The highest dose of the polymer-shelled CA gave results comparable to SonoVue. Thus, no significant difference in the overall segment score distribution (2-47-95 vs. 1-39-104), time for clinically sufficient contrast enhancement (20-40 s for both) and left ventricular overall opacification was found. In contrast, when comparing the endocardial border delineation capacity for different regions SonoVue showed significantly higher segment scores for base and mid, except for the mid region when injecting 1.5 ml of the polymer-shelled CA. Neither high nor low doses of the polymer-shelled CA significantly affected the investigated physiological variables. Conclusions: This study demonstrated that the novel polymer-shelled CA can be used in contrast-enhanced diagnostic imaging without influence on major physiological variables.
|
|
